Glioma Developmental and HyperActive Ras Tumor (DHART) Board | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Glioma Developmental and HyperActive Ras Tumor (DHART) Board	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neuroepithelial neoplasm, neurofibroma, neurofibromatosis, primitive neuroectodermal tumor	Recruiting	Not stated	2026-08-31		NCT05489783

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Memorial Sloan Kettering Cancer Center	753

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)	Basking Ridge	United States	56
Memorial Sloan Kettering Bergen (All Protocol Activities)	Montvale	United States	82
Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York	United States	230
Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown	United States	92
Memorial Sloan Kettering Nassau (All Protocol Activities)	Rockville Centre	United States	6
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)	Commack	United States	20
Memorial Sloan Kettering West Harrison (All Protocol Activities)	Harrison	United States	4